TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 139 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $4,475,000 | -1.9% | 94,321 | -24.3% | 0.52% | -0.6% |
Q1 2015 | $4,563,000 | -32.5% | 124,525 | -26.9% | 0.53% | -44.1% |
Q4 2014 | $6,760,000 | +122.1% | 170,240 | +11.6% | 0.94% | +52.3% |
Q3 2014 | $3,044,000 | +76.6% | 152,595 | +19.7% | 0.62% | +100.3% |
Q4 2013 | $1,724,000 | +18.1% | 127,495 | -0.6% | 0.31% | +6.2% |
Q3 2013 | $1,460,000 | – | 128,312 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |